Characterization of the interaction between the dopamine D4 receptor, KLHL12 and β-arrestins

Kamila Skieterska1, Ao Shen2, Dorien Clarisse1

  • 1Laboratory of GPCR Expression and Signal Transduction (L-GEST), Ghent University, Proeftuinstraat 86, 9000 Ghent, Belgium.

Insights

Beta-arrestins and KLHL12 bind dopamine D4 receptors constitutively. This interaction, along with Cullin3, does not affect receptor ubiquitination or signaling pathways like MAPK.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Dopamine receptors (GPCRs) regulate critical physiological processes.
  • Beta-arrestins modulate GPCR function, including desensitization and signaling.
  • KLHL12, a BTB-Kelch protein, acts as an adaptor in Cullin3-based E3 ligase complexes.

Purpose of the Study:

  • Investigate the molecular basis of KLHL12 and beta-arrestin interaction.
  • Determine the functional relevance of this interaction in dopamine D4 receptor regulation.

Main Methods:

  • Co-immunoprecipitation assays to study protein interactions.
  • Analysis of protein localization and ubiquitination.
  • Beta-arrestin knockout models to assess functional impact.

Main Results:

  • Beta-arrestin 1 and 2 constitutively bind dopamine D4 receptor variants and KLHL12.
  • All three proteins form a macromolecular complex, independent of receptor stimulation.
  • Cullin3 interacts with beta-arrestins, but does not influence their ubiquitination.
  • Beta-arrestin knockout does not affect KLHL12-D4 receptor interaction or receptor ubiquitination.
  • p44/42 MAPK phosphorylation is mediated by Gαi, not KLHL12.

Conclusions:

  • The constitutive interaction between KLHL12, beta-arrestins, and the dopamine D4 receptor is not regulated by receptor stimulation.
  • Beta-arrestins are not essential for KLHL12-mediated dopamine D4 receptor ubiquitination.
  • KLHL12 does not influence beta-arrestin-mediated p44/42 MAPK signaling through the dopamine D4 receptor.

Related Concept Videos

Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
7.0K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
4.3K
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
3.4K